维普中文期刊产品整合服务
94篇 您的检索式:作者名="LEWIECKI EM"
    题名 作者 年代 出处 被引量
1Sclerostin: a novel target for intervention in the treatment of osteoporosis显示文摘Lewiecki EM 2011Discovery Medicine2011,12,65:1
2New targets for intervention in the treatment of post-menopausal osteoporosis 显示文摘Lewiecki EM 2011Nat Rev Rheumatol2011,7,11:1
3Clinical use of serum and urine bone markers in the management of osteoporosis显示文摘Srivastava AK Vliet EL Lewiecki EM 2005Curr Med Res Opin2005,21,7:1
4Clinical applications of bone density testing for osteo- porosis 显示文摘Lewiecki EM 2005Minerva Med2005,96,:1
5Skeletal effects of primary hyperpara-thyroidism:bone mineral density and fracture risk 显示文摘Lewiecki EM Miller PD 2013J ClinDensitom2013,16,1:1
6Sclerostin: a novel target for intervention in the treatment of osteoporosis显示文摘Lewiecki EM 2011Discov Med2011,12,:1
7National Osteoporosis Foundation Clinician' s Guide to Prevention and Treatment of Osteoporosis 2008显示文摘Watts NB Lewiecki EM Miller PD 2008J Clin Densitom2008,11,4:1
8The pathophysiology and treatment of osteoporosis显示文摘Drake MT Clarke BL Lewiecki EM 2015Clin Ther2015,37,:1
9National Os tcoporosis Foundation Clinician's Guide to Prevention and Treat ment of Osteoporosis 2008 显示文摘WATTS NB LEWIECKI EM MILLER PD 2008J Clin Densitom2008,11,4:1
10Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD显示文摘Lewiecki EM Miller PD McClung MR 2007J Bone Miner Res2007,22,12:1
11Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis显示文摘Lewiecki EM 2009J Women''s Health2009,18,10:1
12Update on osteoporosis from the 2014 Santa Fe Bone symposium 显示文摘Lewiecki EM Bilezikian JP Binkley N 2015Endocrine Research2015,25,:1
13Peripheral bone densitometry:clinical applications显示文摘Eis SR Lewiecki EM 2006Arq Bras Endocrinol Metabol2006,50,4:1
14Assessing response to osteoporo- sis therapy 显示文摘Lewiecki EM Watts NB 2008Osteoporos Int2008,19,:1
15Treatment of osteoporosis with denosumab 显示文摘Lewiecki EM 2010Maturitas2010,66,:1
16Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD显示文摘LEWIECKI EM MILLER PD McCLUNG MR 2007J Bone Miner Res2007,22,12:1
17Skeletal effects of primary hyperparathyroi dism: bone mineral density and fracture risk 显示文摘Lewiecki EM Miller PD 2013J Clin Densitom2013,16,1:1
18International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions显示文摘Lewiecki EM Gordon CM Bairn S 2008Bone2008,43,:1
19Sclerostin a novel target for intervention in the treat ment of osteoporosis显示文摘Lewiecki EM 0,,65:1
20Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long - term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial显示文摘Miller PD Bolognese MA Lewiecki EM 2008Bone2008,43,2:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费